Bronchiolitis Acute Viral
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Bronchiolitis Acute Viral trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Bronchiolitis Acute Viral trials you may qualify forAntimicrobial resistance (AMR), considered one of the greatest global threats by the WHO, justifies the development of initiatives to promote appropriate antibi…
The aim of the trial is to evaluate whether the use of oral prednisolone directed by point-of-care testing is useful in acute wheezing caused by rhinovirus in c…
Acute bronchiolitis in infants, mainly caused by the Respiratory Syncytial Virus (RSV), is a public health issue, in terms of morbidity and hospital costs. Nir…
Bronchiolitis obliterans (BO) is the well-known manifestation of the chronic pulmonary graft-versus-host disease(GVHD) after allogeneic hematopoietic stem cell…
Medical practice variability refers to differences in treatment and clinical outcomes that cannot be solely explained by patient characteristics or medical cond…
The purpose of this observational study is to identify the risk factors that make bronchiolitis more severe in infants and toddlers. Bronchiolitis is a common v…
Severe acute viral bronchiolitis is the leading cause of pediatric intensive care admission. The first-line recommended ventilation support is continuous positi…